Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA
Primary Purpose
Pediatric ALL, Cardiac Arrest, Cardiopulmonary Arrest
Status
Completed
Phase
Not Applicable
Locations
Switzerland
Study Type
Interventional
Intervention
i-gel ® device
bag-valve-mask ventilation
Sponsored by
About this trial
This is an interventional treatment trial for Pediatric ALL
Eligibility Criteria
Inclusion Criteria:
- Being a registered EMT, or paramedic
Exclusion Criteria:
- Member of the study team
Sites / Locations
- ACE Genève Ambulances
- Ambulances de la Ville de Sion
- Genève TEAM Ambulances
- SK Ambulances
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Bag-valve-mask ventilation
Supraglottic airway device ventilation
Arm Description
Providers will perform a cardiopulmonary resuscitation, and deliver ventilations using a bag-valve-mask
Providers will perform a cardiopulmonary resuscitation, and deliver ventilations using an i-gel® supraglottic airway device
Outcomes
Primary Outcome Measures
Alveolar ventilation per minute
It will be determined by subtracting the dead space volume from each ventilation, then multiplied by the ventilations' count, and divided by the duration of the ventilation period (i.e., 10 minutes - time to the first ventilation). The simulated child's dead space volume corresponds to about 27 ml using the formula proposed by Numa and Newth. The physiological tidal volume range is of 5 to 8 ml/kg, corresponding to 45 to 72 ml for the simulated child's.
Secondary Outcome Measures
The proportion, and number of ventilations below, within and over the target volume
The target volume is 45 to 72 ml.
The time to the first efficient ventilation
Corresponds to the time elapsed between T0 (the first therapeutical action) and the first efficient ventilation (equal or superior to 45 ml)
The time to the first compression
Corresponds to the time elapsed between T0 (the first therapeutical action) and the first compression
The chest compression fraction
Corresponds to the time during which compressions have been performed on the total CPR time
The chest compression rate
Corresponds to the number of compressions delivered by minute
The proportion of chest compressions below, within and over the target rate
The target rate is 100 to 120 compressions per minute
The compression depth
Corresponds to the depth of the chest compressions
The proportion of chest compressions below and within the target depth
The threshold is 4.3 cm (corresponding to one third of the manikin's measured anteroposterior chest depth)
The proportion of complete chest recoil
Corresponds to the proportions of compression released to at least 5 mm from the baseline
The time to first epinephrine injection
Corresponds to the time elapsed between the first therapeutical action (T0) and the time-point where epinephrine is administered
The proportion of scenarios in which epinephrine is administered within 5 minutes
The part of scenarios where epinephrine was administered following the recommandations
Full Information
NCT ID
NCT05498402
First Posted
August 9, 2022
Last Updated
September 15, 2023
Sponsor
Geneve TEAM Ambulances
Collaborators
ESAMB - College of Higher Education in Ambulance Care, Ambulances de la Ville de Sion, University Hospital, Geneva
1. Study Identification
Unique Protocol Identification Number
NCT05498402
Brief Title
Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA
Official Title
Effect of Intermediate Airway Management Using an I-gel® on Ventilation Parameters in Simulated Pediatric Out-of-Hospital Cardiac Arrest: Protocol for a Randomized Crossover Trial
Study Type
Interventional
2. Study Status
Record Verification Date
September 2023
Overall Recruitment Status
Completed
Study Start Date
January 30, 2023 (Actual)
Primary Completion Date
June 13, 2023 (Actual)
Study Completion Date
June 13, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Geneve TEAM Ambulances
Collaborators
ESAMB - College of Higher Education in Ambulance Care, Ambulances de la Ville de Sion, University Hospital, Geneva
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Pediatric cardiac arrest occurs most in the prehospital setting. Most of them are due to respiratory failure (e.g., trauma, drowning, respiratory distress), where hypoxia leads to cardiac arrest. Generally, emergency medical services (EMS) first use basic airway management techniques i.e., the use of a bag-valve-mask (BVM) device, to restore oxygenation in pediatric OHCA victims. However, these devices present many drawbacks and limitations. Intermediate airway management, i.e., the use of SGA devices, especially the i-gel® has several advantages. It has been shown to enhance both circulatory and ventilatory parameters. There is increasing evidence that IAM devices can safely be used in children. In two pediatric studies of OHCA, American paramedics had significantly higher success rates with SGA devices than with TI. A neonatal animal model showed that the use of SGA was feasible and non-inferior to TI in this population. However, data regarding the effect of IAM with an i-gel® versus the use of a BVM on ventilation parameters during pediatric OHCA is missing. The hypothesis underlying this study is that, in case of pediatric OHCA, early insertion of an i-gel® device without prior BVM ventilation should improve ventilation parameters in comparison with the standard approach consisting in BVM ventilations.
Detailed Description
Pediatric cardiac arrest is a high-risk, low-frequency event associated with death or severe neurological sequelae in survivors. Most occur in the prehospital setting. Despite advances in resuscitation science and survival improvement over the last decades, survival remains low, with only approximately 6% to 20% of children surviving to hospital discharge after pediatric out-of-hospital cardiac arrest (OHCA). Most triggers of pediatric OHCA are respiratory in nature, with sudden infant death syndrome, trauma and drowning among the main etiologies, where hypoxia leads to cardiac arrest. Prompt and effective airway management is therefore paramount when responding to a pediatric OHCA. Any delay in intermediate or advanced airway management has been associated with a decreased chance of survival. The debate about the optimal airway management strategy that should be used in pediatric OHCA is, however, still ongoing.
Generally, emergency medical services (EMS) first use basic airway management techniques i.e., the use of a bag-valve-mask (BVM) device, to restore oxygenation in pediatric OHCA victims. However, these devices present many drawbacks and limitations. First, airtightness must be ensured to enable adequate oxygenation. Second, the use of BVM is associated with gastric air insufflation. This can alter oxygenation by restricting total lung capacity and, consequently, lung compliance. Since decreased lung compliance requires the use of higher pressures to reach the same tidal volume, gastric inflation can indirectly impair venous return. In addition, chest compressions during cardiopulmonary resuscitation (CPR) must be interrupted to provide ventilations when basic airway management devices are used. However, these interruptions decrease coronary and cerebral blood flow and should be minimized as they have been associated with decreased survival both in animals and humans.
On the other hand, advanced airway management, i.e., tracheal intubation (TI), provides optimal airtightness -thereby avoiding gastric inflation and risk of regurgitation- while allowing the provision of asynchronous ventilations during CPR. However, advanced airway management requires advanced skills that must be maintained through regular practice. Depending on the regional context, skilled prehospital providers may not be immediately available, if at all. This is particularly important when taking care of critically ill children, whom many consider difficult to intubate. The failure rate of TI at first attempt in case of pediatric CPR is high, even in the hospital setting, and associated with unfavorable neurological and survival outcomes. Recently, a registry-based study reported these outcomes to be worse after pediatric OHCA when emergency physicians used TI rather than supraglottic airway (SGA) devices. The interpretation of these results is however limited by the lack of data regarding physician experience and TI attempts.
In line with the above listed limitations of basic or advanced airway management devices, intermediate airway management (IAM) i.e., the use of SGA devices [18], could represent a valuable alternative in prehospital settings. One of the best studied SGA devices is the i-gel®, which is both easy and fast to insert, and provides high leak pressures. Its use is associated with a high overall success rate and is easily remembered. Regurgitation and aspiration are not more frequent with IAM devices than with TI and are much less likely than when a BVM device is used. The use of an i-gel® enables continuous chest compressions in most cases, and a higher first rate of successful initial ventilation. This device has been found to increase the chest compression fraction (CCF) and improve ventilations parameters in an adult model of OHCA. In real OHCA, compared to TI, similar outcomes at 30 days and 6 months were found.
There is increasing evidence that IAM devices can safely be used in children. In two pediatric studies of OHCA, American paramedics had significantly higher success rates with SGA devices than with TI. A neonatal animal model showed that the use of SGA was feasible and non-inferior to TI in this population. However, data regarding the effect of IAM with an i-gel® versus the use of a BVM on ventilation parameters during pediatric OHCA is missing. The hypothesis underlying this study is that, in case of pediatric OHCA, early insertion of an i-gel® device without prior BVM ventilation should improve ventilation parameters in comparison with the standard approach consisting in BVM ventilations.
For this purpose, a prospective, multicenter, crossover, randomized controlled trial with two groups will be conduct in four EMS in different French-speaking part of Switzerland. This will be a simulation-based study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pediatric ALL, Cardiac Arrest, Cardiopulmonary Arrest, Resuscitation, Pediatric Emergency Medicine
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Prospective, multicenter, crossover, simulation-based, randomized controlled trial
Masking
Outcomes Assessor
Masking Description
Data extraction will be fully automated and the statistician will not know the identity of the participants or the sequence they were allocated to.
Allocation
Randomized
Enrollment
34 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Bag-valve-mask ventilation
Arm Type
Active Comparator
Arm Description
Providers will perform a cardiopulmonary resuscitation, and deliver ventilations using a bag-valve-mask
Arm Title
Supraglottic airway device ventilation
Arm Type
Experimental
Arm Description
Providers will perform a cardiopulmonary resuscitation, and deliver ventilations using an i-gel® supraglottic airway device
Intervention Type
Device
Intervention Name(s)
i-gel ® device
Intervention Description
Ventilations will be delivered through an i-gel ® device
Intervention Type
Device
Intervention Name(s)
bag-valve-mask ventilation
Intervention Description
Ventilations will be delivered using a bag-valve-mask
Primary Outcome Measure Information:
Title
Alveolar ventilation per minute
Description
It will be determined by subtracting the dead space volume from each ventilation, then multiplied by the ventilations' count, and divided by the duration of the ventilation period (i.e., 10 minutes - time to the first ventilation). The simulated child's dead space volume corresponds to about 27 ml using the formula proposed by Numa and Newth. The physiological tidal volume range is of 5 to 8 ml/kg, corresponding to 45 to 72 ml for the simulated child's.
Time Frame
10 minutes of scenario
Secondary Outcome Measure Information:
Title
The proportion, and number of ventilations below, within and over the target volume
Description
The target volume is 45 to 72 ml.
Time Frame
10 minutes of scenario
Title
The time to the first efficient ventilation
Description
Corresponds to the time elapsed between T0 (the first therapeutical action) and the first efficient ventilation (equal or superior to 45 ml)
Time Frame
10 minutes of scenario
Title
The time to the first compression
Description
Corresponds to the time elapsed between T0 (the first therapeutical action) and the first compression
Time Frame
10 minutes of scenario
Title
The chest compression fraction
Description
Corresponds to the time during which compressions have been performed on the total CPR time
Time Frame
10 minutes of scenario
Title
The chest compression rate
Description
Corresponds to the number of compressions delivered by minute
Time Frame
10 minutes of scenario
Title
The proportion of chest compressions below, within and over the target rate
Description
The target rate is 100 to 120 compressions per minute
Time Frame
10 minutes of scenario
Title
The compression depth
Description
Corresponds to the depth of the chest compressions
Time Frame
10 minutes of scenario
Title
The proportion of chest compressions below and within the target depth
Description
The threshold is 4.3 cm (corresponding to one third of the manikin's measured anteroposterior chest depth)
Time Frame
10 minutes of scenario
Title
The proportion of complete chest recoil
Description
Corresponds to the proportions of compression released to at least 5 mm from the baseline
Time Frame
10 minutes of scenario
Title
The time to first epinephrine injection
Description
Corresponds to the time elapsed between the first therapeutical action (T0) and the time-point where epinephrine is administered
Time Frame
10 minutes of scenario
Title
The proportion of scenarios in which epinephrine is administered within 5 minutes
Description
The part of scenarios where epinephrine was administered following the recommandations
Time Frame
10 minutes of scenario
10. Eligibility
Sex
All
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Being a registered EMT, or paramedic
Exclusion Criteria:
Member of the study team
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Loric Stuby
Organizational Affiliation
Genève TEAM Ambulances
Official's Role
Principal Investigator
Facility Information:
Facility Name
ACE Genève Ambulances
City
Chêne-Bougeries
State/Province
Geneva
ZIP/Postal Code
1224
Country
Switzerland
Facility Name
Ambulances de la Ville de Sion
City
Sion
State/Province
Valais
ZIP/Postal Code
1950
Country
Switzerland
Facility Name
Genève TEAM Ambulances
City
Geneva
ZIP/Postal Code
1201
Country
Switzerland
Facility Name
SK Ambulances
City
Geneva
ZIP/Postal Code
1211
Country
Switzerland
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
The study protocol will be published in a peer-reviewed journal. The data will be freely available on Yareta
IPD Sharing Time Frame
We plan to submit the protocol for publication in the second semester of 2022. The study's data will be accessible once the results submitted for publication
IPD Sharing Access Criteria
The data would be accessible freely on Yareta
Links:
URL
https://swiss-cpr-studies.ch/
Description
Whole project website
Learn more about this trial
Effect of IAM With an I-gel® on Ventilation Parameters in Simulated Pediatric OHCA
We'll reach out to this number within 24 hrs